Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14797831 | 0.94 | KDM4E (0.36) | KDM4ETSHRTDP1 | |
| SCHEMBL3873381 | 0.91 | TSHR (0.34) | KDM4ETSHRTDP1 | |
| SCHEMBL10879855 | 0.91 | TSHR (0.34) | KDM4ETSHRTDP1 | |
| SCHEMBL3025513 | 0.91 | TSHR (0.34) | KDM4ETSHRTDP1 | |
| SCHEMBL2689936 | 0.91 | TSHR (0.34) | KDM4ETSHRTDP1 | |
| SCHEMBL525795 | 0.83 | KDM4E (0.50) | KDM4ETSHRTDP1 | |
| SCHEMBL2695677 | 0.80 | — | — | |
| SCHEMBL498059 | 0.75 | KDM4E (0.43) | KDM4ETSHRTDP1 | |
| SCHEMBL7061998 | 0.75 | KDM4E (0.41) | KDM4ETSHRTDP1 | |
| SCHEMBL28635797 | 0.73 | LMNA (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240322244-A1 | LOCALIZED HIGH CONCENTRATION ELECTROLYTE AND LITHIUM-ION BATTERY COMPRISING THE SAME | SILA NANOTECHNOLOGIES, INC. | 2024-09-26 | — | — | US | claimed |
| WO-2024196936-A2 | LOCALIZED HIGH CONCENTRATION ELECTROLYTE AND LITHIUM-ION BATTERY COMPRISING THE SAME | SILA NANOTECHNOLOGIES, INC. (US) | 2024-09-26 | — | — | WO | claimed |
| CN-118436795-A | Prodrug for regulating and controlling tumor hypoxia and immunosuppression microenvironment, nano assembly, preparation method and application | 沈阳药科大学 | 2024-08-06 | — | — | CN | claimed |
| CN-118165445-A | Polyimide in-situ modified polytetrafluoroethylene membrane material and preparation method and application thereof | 四川大学 | 2024-06-11 | — | — | CN | claimed |
| CN-111333502-A | Method for separating perfluorodiacyl fluoride isomer | 中蓝晨光化工研究设计院有限公司 | 2020-06-26 | — | — | CN | claimed |
| WO-2024196936-A2 | LOCALIZED HIGH CONCENTRATION ELECTROLYTE AND LITHIUM-ION BATTERY COMPRISING THE SAME | SILA NANOTECHNOLOGIES, INC. (US) | 2024-09-26 | — | — | WO | disclosed |
| US-20240322244-A1 | LOCALIZED HIGH CONCENTRATION ELECTROLYTE AND LITHIUM-ION BATTERY COMPRISING THE SAME | SILA NANOTECHNOLOGIES, INC. | 2024-09-26 | — | — | US | disclosed |
| CN-118165445-A | Polyimide in-situ modified polytetrafluoroethylene membrane material and preparation method and application thereof | 四川大学 | 2024-06-11 | — | — | CN | disclosed |
| WO-2024091183-A1 | POLYMERS FOR INTRACELLULAR DELIVERY OF POLYNUCLEOTIDES | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2024-05-02 | — | — | WO | disclosed |
| CN-111333502-B | Method for separating perfluorodiacyl fluoride isomer | 中蓝晨光化工研究设计院有限公司 | 2022-11-01 | — | — | CN | disclosed |
| CN-111138659-B | Method for preparing triblock nonionic fluorine-containing short-chain surfactant by non-isocyanate route | 四川大学 | 2021-04-23 | — | — | CN | disclosed |
| CN-111138658-B | Method for preparing two-block nonionic fluorine-containing short-chain surfactant by non-isocyanate route | 四川大学 | 2021-04-23 | — | — | CN | disclosed |
| US-20130189618-A1 | METHOD OF FORMING RESIST PATTERN | TOKYO OHKA KOGYO CO., LTD (JP) | 2013-07-25 | — | — | US | disclosed |
| US-20130177854-A1 | RESIST COMPOSITION, METHOD OF FORMING RESIST PATTERN AND NOVEL COMPOUND | TOKYO OHKA KOGYO CO., LTD. (JP) | 2013-07-11 | — | — | US | disclosed |
| US-20130115555-A1 | RESIST COMPOSITION AND METHOD OF FORMING RESIST PATTERN | TOKYO OHKA KOGYO CO., LTD. (JP) | 2013-05-09 | — | — | US | disclosed |
| US-20130084523-A1 | RESIST COMPOSITIOIN AND METHOD OF FORMING RESIST PATTERN | TOKYO OHKA KOGYO CO., LTD. (JP) | 2013-04-04 | — | — | US | disclosed |
| US-20130078572-A1 | RESIST COMPOSITION AND METHOD OF FORMING RESIST PATTERN | TOKYO OHKA KOGYO CO., LTD. (JP) | 2013-03-28 | — | — | US | disclosed |
| US-20100171108-A1 | USE OF N,N'-BIS(1,1-DIHYDROPERFLUORO-C3-C5-ALKYL)-PERYLENE-3,4:9,10- TETRACARBOXYLIC DIIMIDES | BASF SE (DE) | 2010-07-08 | — | — | US | disclosed |
| EP-2170862-A1 | USE OF N,N'-BIS(1,1-DIHYDROPERFLUORO-C3-C5-ALKYL)PERYLENE-3,4:9,10-TETRACARBOXYLIC DIIMIDES | BASF SE (DE) | 2010-04-07 | — | — | EP | disclosed |
| WO-2009000756-A1 | USE OF N,N'-BIS(1,1-DIHYDROPERFLUORO-C3-C5-ALKYL)PERYLENE-3,4:9,10-TETRACARBOXYLIC DIIMIDES | BASF SE (DE) | 2008-12-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100171108-A1 | USE OF N,N'-BIS(1,1-DIHYDROPERFLUORO-C3-C5-ALKYL)-PERYLENE-3,4:9,10- TETRACARBOXYLIC DIIMIDES | SLC1A1, SLC1A3, HCN1 | KDM4E 3613/4885TSHR 4659/4885TDP1 1774/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.